National Institute of Neurological Disorders and Stroke, 40780-40781 [2017-18200]
Download as PDF
<![CDATA[
40780
Federal Register / Vol. 82, No. 165 / Monday, August 28, 2017 / Notices
Biomedical Imaging and Bioengineering
Special Emphasis Panel.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Biomedical Imaging and Bioengineering
Special Emphasis Panel, NIBIB P41 Review
(2018/01).
Date: September 17–19, 2017.
Time: 5:00 p.m. to 12:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Courtyard Los Angeles LA Live, 901
West Olympic Boulevard, Los Angeles, CA
90015.
Contact Person: Ruixia Zhou, Ph.D.,
Scientific Review Officer, 6707 Democracy
Boulevard, Democracy Two Building, Suite
957, Bethesda, MD 20892, (301) 496–4773,
zhour@mail.nih.gov.
Dated: August 22, 2017.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2017–18122 Filed 8–25–17; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
asabaliauskas on DSKBBXCHB2PROD with NOTICES
National Institute of Biomedical
Imaging and Bioengineering Notice of
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
meeting of the National Advisory
Council for Biomedical Imaging and
Bioengineering.
The meeting will be open to the
public as indicated below, with
attendance limited to space available.
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications
and/or contract proposals and the
discussions could disclose confidential
VerDate Sep<11>2014
18:45 Aug 25, 2017
Jkt 241001
trade secrets or commercial property
such as patentable material, and
personal information concerning
individuals associated with the grant
applications and/or contract proposals,
the disclosure of which would
constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Advisory
Council for Biomedical Imaging and
Bioengineering NACBIB Council Meeting,
September, 2017.
Date: September 12, 2017.
Open: 9:00 a.m. to 12:40 p.m.
Agenda: Report from the Institute Director,
other Institute Staff and scientific
presentation.
Place: The William F. Bolger Center,
Franklin Building, Classroom 4, 9600
Newbridge Drive, Potomac, MD 20854.
Closed: 2:00 p.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications and/or proposals.
Place: The William F. Bolger Center,
Franklin Building, Classroom 4, 9600
Newbridge Drive, Potomac, MD 20854.
Contact Person: David T. George, Ph.D.,
Acting Associate Director, Office of Research
Administration, National Institute of
Biomedical Imaging and Bioengineering,
6707 Democracy Boulevard, Room 920,
Bethesda, MD 20892.
Any interested person may file
written comments with the committee
by forwarding the statement to the
Contact Person listed on this notice. The
statement should include the name,
address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
Information is also available on the
Institute’s/Center’s home page: https://
www.nibib1.nih.gov/about/NACBIB/
NACBIB.htm, where an agenda and any
additional information for the meeting
will be posted when available.
Dated: August 22, 2017.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2017–18120 Filed 8–25–17; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Neurological
Disorders and Stroke
Pursuant to section 10(a) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of an
Interagency Pain Research Coordinating
Committee (IPRCC) meeting.
The meeting will feature invited
speakers and discussions of committee
business items including updates on the
PO 00000
Frm 00037
Fmt 4703
Sfmt 4703
Federal Pain Research Strategy and new
pain initiatives.
The meeting will be open to the
public and accessible by live webcast
and conference call.
Name of Committee: Interagency Pain
Research Coordinating Committee.
Type of meeting: Open Meeting.
Date: October 23, 2017.
Time: 8:30 a.m. to 4:30 p.m. *Eastern
Time*—Approximate end time.
Agenda: The meeting will feature invited
speakers and discussions of Committee
business items including updates on the
Federal Pain Research Strategy and new pain
initiatives.
Place: National Institutes of Health,
Building 31C, 6th Floor, Room 6, 31 Center
Drive, Bethesda, MD 20892.
Cost: The meeting is free and open to the
public.
Webcast Live: https://videocast.nih.gov/.
Deadlines: Notification of intent to present
oral comments: Monday, October 17, 2017,
by 5:00 p.m. ET. Submission of written/
electronic statement for oral comments:
Monday, October 17, 2017, by 5:00 p.m. ET.
Submission of written comments: Monday,
October 17, 2017, by 5:00 p.m. ET.
Access: Medical Center Metro (Red Line).
Visitor Information: https://www.nih.gov/
about/visitor/index.htm.
Contact Person: Linda L. Porter, Ph.D.,
Pain Policy Advisor, Office of Pain Policy,
Officer of the Director, National Institute of
Neurological Disorders and Stroke, NIH, 31
Center Drive, Room 8A31, Bethesda, MD
20892, Phone: (301) 451–4460, Email:
Linda.Porter@nih.gov.
Please Note: Any member of the public
interested in presenting oral comments to the
Committee must notify the Contact Person
listed on this notice by 5:00 p.m. ET on
Monday, October 17, 2017, with their request
to present oral comments at the meeting.
Interested individuals and representatives of
organizations must submit a written/
electronic copy of the oral statement/
comments including a brief description of the
organization represented by 5:00 p.m. ET on
Monday, October 17, 2017.
Statements submitted will become a part of
the public record. Only one representative of
an organization will be allowed to present
oral comments on behalf of that organization,
and presentations will be limited to three to
five minutes per speaker, depending on
number of speakers to be accommodated
within the allotted time. Speakers will be
assigned a time to speak in the order of the
date and time when their request to speak is
received, along with the required submission
of the written/electronic statement by the
specified deadline. If special
accommodations are needed, please email
the Contact Person listed above.
In addition, any interested person may
submit written comments to the IPRCC prior
to the meeting by sending the comments to
the Contact Person listed on this notice by
5:00 p.m. ET, Monday, October 17, 2017. The
comments should include the name and,
when applicable, the business or professional
affiliation of the interested person. All
written comments received by the deadlines
E:\FR\FM\28AUN1.SGM
28AUN1
Federal Register / Vol. 82, No. 165 / Monday, August 28, 2017 / Notices
for both oral and written public comments
will be provided to the IPRCC for their
consideration and will become part of the
public record.
The meeting will be open to the public and
webcast live on the Internet. If you
experience any technical problems with the
webcast, please call the NIH IT Service Desk
at (301) 496–4357, toll free (866) 319–4357,
for webcast issues.
Individuals who participate in person or by
using the web service and who need special
assistance, such as captioning, should submit
a request to the Contact Person listed on this
notice at least seven days prior to the
meeting.
As a part of security procedures, attendees
should be prepared to present a photo ID
during the security process to get on the NIH
campus. For a full description, please see:
https://www.nih.gov/about/
visitorsecurity.htm.
Information about the IPRCC is available
on the Web site: https://iprcc.nih.gov/.
Dated: August 23, 2017.
Sylvia L. Neal,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2017–18200 Filed 8–25–17; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Aging; Notice of
Closed Meeting
asabaliauskas on DSKBBXCHB2PROD with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Aging Initial Review Group; Neuroscience of
Aging Review Committee.
Date: October 5–6, 2017.
Time: 2:00 p.m. to 2:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Bethesda Marriott, 5151 Pooks Hill
Road, Bethesda, MD 20814.
Contact Person: Greg Bissonette, Ph.D.,
Scientific Review Officer, National Institute
on Aging, National Institutes of Health,
Gateway Building, Suite 2W200, 7201
Wisconsin Avenue, Bethesda, MD 20892,
301–402–1622, bissonettegb@mail.nih.gov.
VerDate Sep<11>2014
18:45 Aug 25, 2017
Jkt 241001
(Catalogue of Federal Domestic Assistance
Program Nos. 93.866, Aging Research,
National Institutes of Health, HHS)
Dated: August 23, 2017.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2017–18198 Filed 8–25–17; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center For Scientific Review; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Oncology 2—
Translational Clinical Integrated Review
Group; Basic Mechanisms of Cancer
Therapeutics Study Section.
Date: September 18–19, 2017.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Double Tree Suites by Hilton. 1707
Fourth Street. Santa Monica, CA 90401.
Contact Person: Lambratu Rahman Sesay,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6214,
MSC 7804, Bethesda, MD 20892, 301–451–
3493, rahman-sesayl@csr.nih.gov.
Name of Committee: Surgical Sciences,
Biomedical Imaging and Bioengineering
Integrated Review Group; Biomedical
Imaging Technology A Study Section.
Date: September 26–27, 2017.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Bethesda North Marriott Hotel &
Conference Center, Montgomery County
Conference Center Facility, 5701 Marinelli
Road, North Bethesda, MD 20852.
Contact Person: Ruth Grossman, DDS,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5215,
Bethesda, MD 20892, (301) 435–2409,
grossmanrs@mail.nih.gov.
Name of Committee: Surgical Sciences,
Biomedical Imaging and Bioengineering
PO 00000
Frm 00038
Fmt 4703
Sfmt 4703
40781
Integrated Review Group; Medical Imaging
Study Section.
Date: September 26–27, 2017.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Bethesda North Marriott Hotel &
Conference Center, 5701 Marinelli Road,
Bethesda, MD 20852.
Contact Person: Xiang-Ning Li, MD, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5112,
MSC 7854, Bethesda, MD 20892, 301–435–
1744, lixiang@csr.nih.gov.
Name of Committee: Surgical Sciences,
Biomedical Imaging and Bioengineering
Integrated Review Group; Clinical Molecular
Imaging and Probe Development.
Date: September 26–27, 2017.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Bethesda North Marriott Hotel &
Conference Center, Montgomery County
Conference Center Facility, 5701 Marinelli
Road, North Bethesda, MD 20852.
Contact Person: Donald Scott Wright,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5108,
MSC 7854, Bethesda, MD 20892, (301) 435–
8363, wrightds@csr.nih.gov.
Name of Committee: Surgical Sciences,
Biomedical Imaging and Bioengineering
Integrated Review Group; Biomedical
Imaging Technology B Study Section.
Date: September 26–27, 2017.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Bethesda North Marriott Hotel &
Conference Center, 5701 Marinelli Road,
Bethesda, MD 20852.
Contact Person: Mehrdad Mohseni, MD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5211,
MSC 7854, Bethesda, MD 20892, 301–435–
0484, mohsenim@csr.nih.gov.
Name of Committee: Cardiovascular and
Respiratory Sciences Integrated Review
Group; Lung Cellular, Molecular, and
Immunobiology Study Section.
Date: September 26–27, 2017.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Bahia Resort Hotel, 998 West
Mission Bay Drive, San Diego, CA 92109.
Contact Person: George M. Barnas, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 2180,
MSC 7818, Bethesda, MD 20892, 301–435–
0696, barnasg@csr.nih.gov.
Name of Committee: Center for Scientific
Review, Special Emphasis Panel, PAR 16–
304: Behavioral and Psychological
Phenotypes Contributing to Obesity.
Date: September 26, 2017.
Time: 4:00 p.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
E:\FR\FM\28AUN1.SGM
28AUN1
]]>Agencies
[Federal Register Volume 82, Number 165 (Monday, August 28, 2017)]
[Notices]
[Pages 40780-40781]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-18200]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Neurological Disorders and Stroke
Pursuant to section 10(a) of the Federal Advisory Committee Act, as
amended, notice is hereby given of an Interagency Pain Research
Coordinating Committee (IPRCC) meeting.
The meeting will feature invited speakers and discussions of
committee business items including updates on the Federal Pain Research
Strategy and new pain initiatives.
The meeting will be open to the public and accessible by live
webcast and conference call.
Name of Committee: Interagency Pain Research Coordinating
Committee.
Type of meeting: Open Meeting.
Date: October 23, 2017.
Time: 8:30 a.m. to 4:30 p.m. *Eastern Time*--Approximate end
time.
Agenda: The meeting will feature invited speakers and
discussions of Committee business items including updates on the
Federal Pain Research Strategy and new pain initiatives.
Place: National Institutes of Health, Building 31C, 6th Floor,
Room 6, 31 Center Drive, Bethesda, MD 20892.
Cost: The meeting is free and open to the public.
Webcast Live: https://videocast.nih.gov/.
Deadlines: Notification of intent to present oral comments:
Monday, October 17, 2017, by 5:00 p.m. ET. Submission of written/
electronic statement for oral comments: Monday, October 17, 2017, by
5:00 p.m. ET. Submission of written comments: Monday, October 17,
2017, by 5:00 p.m. ET.
Access: Medical Center Metro (Red Line). Visitor Information:
https://www.nih.gov/about/visitor/index.htm.
Contact Person: Linda L. Porter, Ph.D., Pain Policy Advisor,
Office of Pain Policy, Officer of the Director, National Institute
of Neurological Disorders and Stroke, NIH, 31 Center Drive, Room
8A31, Bethesda, MD 20892, Phone: (301) 451-4460, Email:
Linda.Porter@nih.gov.
Please Note: Any member of the public interested in presenting
oral comments to the Committee must notify the Contact Person listed
on this notice by 5:00 p.m. ET on Monday, October 17, 2017, with
their request to present oral comments at the meeting. Interested
individuals and representatives of organizations must submit a
written/electronic copy of the oral statement/comments including a
brief description of the organization represented by 5:00 p.m. ET on
Monday, October 17, 2017.
Statements submitted will become a part of the public record.
Only one representative of an organization will be allowed to
present oral comments on behalf of that organization, and
presentations will be limited to three to five minutes per speaker,
depending on number of speakers to be accommodated within the
allotted time. Speakers will be assigned a time to speak in the
order of the date and time when their request to speak is received,
along with the required submission of the written/electronic
statement by the specified deadline. If special accommodations are
needed, please email the Contact Person listed above.
In addition, any interested person may submit written comments
to the IPRCC prior to the meeting by sending the comments to the
Contact Person listed on this notice by 5:00 p.m. ET, Monday,
October 17, 2017. The comments should include the name and, when
applicable, the business or professional affiliation of the
interested person. All written comments received by the deadlines
[[Page 40781]]
for both oral and written public comments will be provided to the
IPRCC for their consideration and will become part of the public
record.
The meeting will be open to the public and webcast live on the
Internet. If you experience any technical problems with the webcast,
please call the NIH IT Service Desk at (301) 496-4357, toll free
(866) 319-4357, for webcast issues.
Individuals who participate in person or by using the web
service and who need special assistance, such as captioning, should
submit a request to the Contact Person listed on this notice at
least seven days prior to the meeting.
As a part of security procedures, attendees should be prepared
to present a photo ID during the security process to get on the NIH
campus. For a full description, please see: https://www.nih.gov/about/visitorsecurity.htm.
Information about the IPRCC is available on the Web site: https://iprcc.nih.gov/.
Dated: August 23, 2017.
Sylvia L. Neal,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2017-18200 Filed 8-25-17; 8:45 am]
BILLING CODE 4140-01-P
